Hemostemix (HEM) Stock Chart & Stock Price History C$0.08 +0.01 (+6.67%) As of 01:15 PM Eastern Add Compare Share Share Chart Stock AnalysisChartHeadlinesInsider TradesBuy This Stock Hemostemix Stock Price Performance The Hemostemix (HEM) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 60.00%, with a year-to-date return of -33.33%. In the past month, the stock has decreased 40.74%, reflecting recent market activity. As of the latest close, Hemostemix traded at C$0.08 with a market cap of C$10.93 million and volume of 2.30 million shares. Receive HEM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hemostemix and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-20.00%1 Month Performance-40.74%3 Month Performance-15.79%Year-To-Date Performance-33.33%1 Year Performance+60.00% HEM Stock Chart for Friday, August, 8, 2025 HEM Chart by TradingView Hemostemix Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/07/2025C$0.10C$0.08-25.00%C$0.11C$0.082.30 million shsC$10.93 million08/06/2025C$0.10C$0.10+5.26%C$0.11C$0.09313,440 shsC$14.57 million08/05/2025C$0.10C$0.10-5.00%C$0.10C$0.09217,955 shsC$13.84 million08/04/2025C$0.10C$0.10C$0.12C$0.10670,435 shsC$14.57 million08/01/2025C$0.12C$0.10-16.67%C$0.12C$0.10670,435 shsC$14.57 million07/31/2025C$0.11C$0.12+9.09%C$0.13C$0.10319,296 shsC$17.49 million07/30/2025C$0.14C$0.11-18.52%C$0.14C$0.11346,857 shsC$16.03 million07/29/2025C$0.14C$0.14-3.57%C$0.14C$0.1391,990 shsC$19.67 million07/28/2025C$0.14C$0.14+3.70%C$0.14C$0.14113,383 shsC$20.40 million07/25/2025C$0.14C$0.14-3.57%C$0.14C$0.142,100 shsC$19.67 million Get the Latest News and Ratings for HEM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hemostemix and its competitors with MarketBeat's FREE daily newsletter. 07/24/2025C$0.13C$0.14+7.69%C$0.14C$0.1460,016 shsC$20.40 million07/23/2025C$0.13C$0.13+4.00%C$0.13C$0.1224,000 shsC$18.95 million07/22/2025C$0.14C$0.13-7.41%C$0.14C$0.13135,170 shsC$18.22 million07/21/2025C$0.14C$0.14C$0.14C$0.1354,853 shsC$19.67 million07/18/2025C$0.14C$0.14C$0.14C$0.1440,000 shsC$19.67 million07/17/2025C$0.14C$0.14-3.57%C$0.14C$0.14135,075 shsC$19.67 million07/16/2025C$0.14C$0.14C$0.15C$0.1466,081 shsC$20.40 million07/15/2025C$0.14C$0.14+3.70%C$0.14C$0.1415,950 shsC$20.40 million07/14/2025C$0.14C$0.14-3.57%C$0.14C$0.1428,500 shsC$19.67 million07/11/2025C$0.14C$0.14+3.70%C$0.15C$0.1480,050 shsC$20.40 million07/10/2025C$0.14C$0.14-3.57%C$0.14C$0.1483,077 shsC$19.67 million07/09/2025C$0.14C$0.14+3.70%C$0.15C$0.14272,977 shsC$20.40 million07/08/2025C$0.15C$0.14-6.90%C$0.15C$0.14313,700 shsC$19.67 million07/07/2025C$0.14C$0.15+3.57%C$0.16C$0.1524,588 shsC$21.13 million Related Companies Covalon Technologies Stock Price Chart Sernova Stock Price Chart Medicenna Therapeutics Stock Price Chart Helix BioPharma Stock Price Chart Microbix Biosystems Stock Price Chart Resverlogix Stock Price Chart Devonian Health Group Stock Price Chart Sirona Biochem Stock Price Chart Innovotech Stock Price Chart Quest PharmaTech Stock Price Chart Receive HEM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hemostemix and its competitors with MarketBeat's FREE daily newsletter. This page (CVE:HEM) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredGold Hit $3,500. Here’s What’s Next…Gold just smashed through $3,500—and some experts believe that’s only the beginning. With big banks like Goldm...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hemostemix Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hemostemix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
